Our Expertise

Advanced Molecular Imaging & Therapy

Cancer Diagnosis

Theranostic = Therapy + Diagnosis

Nuclear Cardiology

Thyroid Imaging and Therapy

Radiolabeled Therapy for Prostate Cancer and Bone Metastasis

Lu-177 DOTA Therapy for Neuroendocrine Tumors

I-131 mIBG Therapy & Y-90 Therapies

Meet Dr. Rashmi Angadi

Bringing Cutting-Edge Theranostics to Hubballi

Dr. Rashmi Angadi is a leading Nuclear Medicine Physician with over 15 years of expertise in molecular imaging and cancer therapy. She is the Founder Director and Chief Consultant at NeuMoD Digital PET-CT & Molecular Theranostics, Hubballi—North Karnataka’s premier center for advanced nuclear medicine.

 

Having performed more than 45,000 PET-CT scans and treated over 1,000 cancer patients using radionuclide therapy, Dr. Angadi specializes in PET-CT imaging, nuclear cardiology, neuro-nuclear procedures, and theranostics. She holds an MBBS from Karnataka Medical College, Hubballi, where she earned five gold medals, and a DNB in Nuclear Medicine from the National Board of Examinations. She’s also a certified Radiation Safety Officer by BARC.

 

She has held key roles at premier institutions like Narayana Hrudayalaya and KLE Hospital, Belagavi, and has received specialized training at AIIMS, New Delhi, and PGI Chandigarh. Dr. Angadi is known for pioneering nuclear medicine access in underserved regions and has been honored as one of the Top 10 Influential Women Leaders of 2025 and excellence award 2025

 

Her patient-centered, evidence-based approach sets new standards in personalized oncology, cardiology, and neurological imaging, making her a trusted name in nuclear medicine across the region.

 

 

Education & Training

• MBBS, 2002, Karnataka Medical College, Hubli, Rajiv Gandhi University of Health Sciences
• DNB, 2011, Narayana Hrudayalaya, Bangalore, National Board of Examinations, New Delhi
• RSO, 2014, BARC, Atomic Energy Regulatory Board, Mumbai

Professional Experience

• Narayana Hrudayalaya and Mazumdar Shaw Cancer care centre, Bangalore (March,2011 – April, 2014)
• KLES Dr. Prabhakar Kore Hospital & JNMC, Belagavi
• Founder, In-Charge & Consultant, Dept. of Nuclear Medicine & PET-CT (2014–2022)
• NeuMoD Digital PET-CT & Molecular Theranostics, Hubballi
• Founder Director & Chief Consultant (Sep 2022 – Present)

Achievements & Awards

• Top 10 Influential Women Leader Award 2025
• Healthcare excellence Award 2025
• Finalist – Mrs. World International Award 2025
• Key contributor to developing nuclear medicine services across North Karnataka
• Active role in national and international theranostic protocols
• Poetess - Published book on her own poems

Professional Memberships

• Society of Nuclear Medicine India (SNMI)
• Association of Nuclear Medicine Physicians of India (ANMPI)
• Indian Medical Association (IMA)
• Association of Family Physicians of India (AFPI)
• Indian Thyroid Society (ITS)
• GOKARMA (Goa-Karnataka-Maharashtra Oncology Association)

Patient Voices

Real stories of healing and trust

Neumod Digital PET-CT in Hubli is a game-changer for North Karnataka. As the only digital PET-CT centre in the region, it offers world-class imaging, accurate reports, and patient-friendly service with the latest technology. Excellent staff, hygienic setup, and faster scans make it a huge boon for patients across Hubli, Dharwad, Belgaum, and beyond. Highly recommended!

Anil Kulkarni

Patient

Nice experience! The centre is very clean and hygienic with a friendly staff and good environment. Reports are shared easily via WhatsApp or courier. Really happy with my visit — thank you Neumod Scan Centre!

Chinnamma Patil

Patient

It was good experience. Doctors provided good treatment. Hospital is clean. Staff are caring and efficient. Dr Rashmi Angadi mam is a compassionate doctor. Highly recommend

Priya Gadamali

Patient

The facility is excellent, and the hospitality is truly commendable. We recently had a PET CT scan done here and received the report within the promised time. Overall, a great experience with efficient service.

Nimya KN

Patient

FAQs

Quick Answers

Q1. 1. Why should I consult Dr. Rashmi Angadi for a PET-CT scan?

Dr. Rashmi Angadi is a leading Nuclear Medicine Consultant in Hubballi with over 45,000+ scans conducted. Her expertise ensures accurate diagnosis and interpretation using advanced digital PET-CT technology at NeuMoD, helping patients get the right treatment at the right time.

Q2. Is radionuclide therapy available with Dr. Rashmi Angadi in Hubballi, North Karnataka?

Yes. Dr. Rashmi Angadi specializes in radionuclide therapy for thyroid, liver, prostate, and neuroendocrine cancers. She provides personalized, evidence-based treatments using radiolabeled agents at her state-of-the-art facility, NeuMoD Digital PET-CT & Molecular Theranostics.

Q3. What types of cancer can Dr. Rashmi Angadi diagnose using PET-CT?

Dr. Rashmi accurately diagnoses and stages cancers like breast, lung, liver, thyroid, pancreas, brain, and gastrointestinal tumors. Her extensive experience ensures early detection and better treatment planning through precision PET-CT imaging.

Q4. Is a PET-CT scan safe at NeuMoD under Dr. Rashmi’s care?

Absolutely. Under Dr. Rashmi Angadi’s supervision, PET-CT scans are performed with utmost safety, using optimized low-dose protocols. She is a certified Radiation Safety Officer (RSO), ensuring patient well-being during every scan.

Q5. How do I prepare for a PET-CT or cancer therapy session with Dr. Rashmi Angadi?

Dr. Rashmi provides clear pre-scan and pre-therapy instructions based on your condition. Typically, you may need to fast for 4–6 hours and avoid exercise. For personalized preparation guidelines, you can directly contact her clinic for assistance.

Blogs

Health Insights

View All

04 Feb 2026

Case Reports

68Ga-FAPI PET-CT in Detecting Disease Progression in Recurrent Ovarian Cancer: A Case Report

Introduction

Ovarian cancer is known for its high recurrence rate and complex metastatic patterns, often involving lymph nodes, peritoneum, omentum, and distant sites. Accurate assessment of disease progression after surgery and chemotherapy is critical for guiding further oncologic management.

68Ga-FAPI PET-CT, a novel molecular imaging modality targeting cancer-associated fibroblasts, has shown superior sensitivity in detecting recurrent and metastatic ovarian cancer, especially in the peritoneum and lymph nodes.

This case highlights the clinical value of 68Ga-FAPI PET-CT in identifying disease progression in a treated ovarian cancer patient

Read More

22 Jan 2026

Health Tips

Role of ⁶⁸Ga-FAPI PET-CT in Follow-Up Assessment of Oesophagogastric Junction Cancer: A Case Report

Cancers of the oesophagogastric junction (OGJ) and proximal stomach are aggressive malignancies where accurate post-treatment assessment is critical for long-term outcomes. Conventional imaging may fail to differentiate residual disease from post-treatment changes.
⁶⁸Ga-FAPI PET-CT, a novel molecular imaging technique targeting cancer-associated fibroblasts, offers superior tumor visualization with low background uptake, making it highly effective in therapy response evaluation.

This case highlights the clinical value of ⁶⁸Ga-FAPI PET-CT in post-chemoradiation follow-up of OGJ carcinoma 

Read More

22 Aug 2025

Case Reports

FDG PET-CT in Initial Staging of Breast Cancer – Case Report | NeuMoD Hubli Dr Rashmi Angadi

Introduction

Breast cancer remains one of the most common malignancies among women worldwide. Early detection and accurate staging play a crucial role in treatment planning and improving patient outcomes. F-18 FDG PET-CT scan has emerged as a powerful diagnostic tool that not only detects the primary tumor but also identifies nodal and distant metastases in a single whole-body evaluation.

This case demonstrates how FDG PET-CT changed the staging and management plan of a breast cancer patient, emphasizing its value as a one-stop solution in oncology.

Read More

View All